ERYTECH PHARMA (ERYP.PA) Stock Analyst Ratings

EPA:ERYP • FR0011471135

0.801 EUR
+0 (+0.25%)
Last: Jun 28, 2023, 07:00 PM
Buy % Consensus

42

ChartMill assigns a Buy % Consensus number of 42% to ERYP.PA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 3.67. This target is 358.43% above the current price.
  • ERYP.PA was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about ERYP.PA.
  • In the previous month the buy percentage consensus was at a similar level.
  • ERYP.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.
ERYP.PA Historical Analyst RatingsERYP.PA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.803.643.673.673.78 - 353.93% 358.43% 358.43% 371.91%
ERYP.PA Current Analyst RatingERYP.PA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades

ERYTECH PHARMA / ERYP.PA FAQ

What is the average price target for ERYTECH PHARMA (ERYP.PA) stock?

9 analysts have analysed ERYP.PA and the average price target is 3.67 EUR. This implies a price increase of 358.43% is expected in the next year compared to the current price of 0.801.


What is the consensus rating for ERYP stock?

The consensus rating for ERYTECH PHARMA (ERYP.PA) is 42.2222 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


What is the number of analysts for ERYP stock?

The number of analysts covering ERYTECH PHARMA (ERYP.PA) is 9.